@article {7520,
	title = {Health-RELATED quality of life from the MM-003 trial of pomalidomide plus LOW-Dose dexamethasone VERSUS HIGH-DOSE dexamethasone in relapsed and/or refractory multiple myeloma},
	journal = {Haematologica},
	volume = {100},
	year = {2015},
	note = {Cited By :8Export Date: 21 February 2017},
	month = {2015},
	pages = {63 - 67},
	keywords = {multiple myeloma, pomalidomide, Quality of Life},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964216471\&doi=10.3324\%2fhaematol.2014.112557\&partnerID=40\&md5=76bfc4ff5b3a812289559bfd289c5695},
	author = {Song, K.W. and Dimopoulos, M.A. and Weisel, K.C. and Moreau, P. and Palumbo, A. and Belch, A. and Schey, S. and Sonneveld, P. and Sternas, L. and Yu, X. and Amatya, R. and Monzini, M.S. and Zaki, M. and Jacques, C. and Miguel, J.S.}
}
